AMG 510 CAS:2252403-56-6 Pharmaceutical Raw Materials  

Product Name:AMG 510

Synonyms:6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-1-[4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL]-4-[(2S)-2-METHYL-4-(P;6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]-1H,2H-pyrido[2,3-d]pyrimidin-2-one;AMG-510;AMG 510;AMG510;AMG 510;4-((S)-4-acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one;chiral AMG 510, single isomer;CPD2809;AMG-510，AMG510

CAS:2252403-56-6

MF:C30H30F2N6O3

MW:560.59

Boiling point:730.5±70.0 °C(Predicted)

density:1.36±0.1 g/cm3(Predicted)

storage temp.:Store at -20°C, stored under nitrogen

solubility:DMSO:75.0(Max Conc. mg/mL);133.78(Max Conc. mM)

Water:33.33(Max Conc. mg/mL);59.45(Max Conc. mM)

Ethanol:8.0(Max Conc. mg/mL);14.27(Max Conc. mM)

Storage:-20°C, stored under nitrogen

Uses:AMG-510 is a KRAS G12C inhibitor thus leading to the regression of KRAS G12C tumors as it interrupts protein signaling.

Description   

AMG-510 is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. AMG-510 irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. AMG-510 is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors.